Table 3.
The relationship between clinical parameters and MPV levels in preterm newborns.
| MPV ≥ 10.2 (n = 136) | MPV < 10.2 (n = 169) | P-value | ||
|---|---|---|---|---|
| Neonatal factor | GA (w) (median) [IQR] | 26.5 [24.3–29.1] | 28.0 [25.9–30.2] | 0.002 |
| BW (g) (median) [IQR] | 739 [596–1,071] | 1,010 [771–1,279] | 0.000 | |
| Male n (%) | 69 (50) | 83 (49) | 0.386 | |
| RDS n (%) | 81 (60) | 99 (59) | 0.430 | |
| SGA n (%) | 29 (21) | 28 (17) | 0.253 | |
| BPD n (%) | 48 (35) | 28 (17) | 0.000 | |
| IVH n (%) | 25 (18) | 29 (17) | 0.429 | |
| NEC n (%) | 5 (3) | 5 (3) | 0.477 | |
| Death n (%) | 22 (16) | 9 (5) | 0.002 | |
| Apgar Score (1 min) (median) [IQR] | 4 [3–6] | 5 [3.5–7] | 0.026 | |
| Apgar Score (5 min) (median) [IQR] | 7 [6–8] | 8 [6–8] | 0.048 | |
| Platelet counts (×104/μl) (median) [IQR] | 18.6 [13.8–24.1] | 22.4 [16.8–26.3] | 0.001 | |
| PCT (%) (median) [IQR] | 0.20 [0.15–0.26] | 0.19 [0.15–0.24] | 0.246 | |
| PDW (%) (median) [IQR] | 11.9 [11.2-13.2] | 10.8 [10.1–15.9] | 0.000 | |
| PMI (fl nl−1) (median) [IQR] | 2,055 [1,516–2,555] | 1,953 [1,489–2,407] | 0.313 | |
| Maternal factor | PROM n (%) | 35 (26) | 69 (40) | 0.366 |
| CAM n (%) | 61(46) | 47 (28) | 0.001 | |
| PA n (%) | 13 (10) | 13 (8) | 0.230 | |
| PIH n (%) | 14 (10) | 25 (15) | 0.111 | |
| HELLP n (%) | 8 (2) | 9 (5) | 0.570 | |
| GDM n (%) | 3 (2) | 4 (2) | 0.233 |
GA, gestational age; BW, birth weight; RDS, respiratory distress syndrome; SGA, small for gestational age; IVH, intraventricular hemorrhage; BPD, bronchopulmonary dysplasia; NEC, necrotizing enterocolitis; PCT, plateletcrit; MPV, mean platelet volume; PDW, platelet distribution width; PMI, Platelet mass index; PROM, preterm rupture of membranes; CAM, chorioamnionitis; PA, placental abruption; PIH, pregnancy-induced hypertension; HELLP, hemolysis, elevated liver enzymes, low platelets; GDM, gestational diabetes mellitus; IQR, interquartile range. Continuous variables are presented as medians.